$BSTG secured Orphan status for its esophageal implant

New Post Public Reply Private Reply Replies (0) Message Board
CollinsIR CollinsIR #1
$BSTG secured Orphan status for its esophageal implant ahead of schedule; It has also updated its guidance - with is esophageal implant IND filing not targeted for Q3 '17 and going into human patients in Q4 '17.

Biostage, Inc. (BSTG) Stock Research Links

BSTG Board Company Profile Buy Rating Time & Sales News Filings Financials
Posts that I make on Investors Hangout reflect my own personal thinking and opinion and are neither endorsed nor approved by the subject companies, many of which may be clients or client prospects of our our NY-based investor relations consulting firm.

David Collins, Managing Director
Catalyst Global Investor Relations
www.catalyst-ir.com
dcc@catatalyst-ir.com
212 924 9800
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Historic Unity Among U.S. Latino Leaders for Mexico's Inauguration

Updated Category News Views 171

U.S. Latino leaders gathered for a historic delegation to Mexico, coinciding with the inauguration of Dra. Claudia Sheinbaum Pardo as Mexico's first female president back in 2024. This was no ordinary trip; it was a strategic move to tighten bonds between the two nations at a pivotal moment, hoping to reshape how Mexican-Americans influenced U.S. policy. Binational Ties:...

Continue Reading
Forecast for Structural Heart Devices Market Growth to USD 25B

Updated Category News Views 171

The Future of Structural Heart Devices Market Growth The structural heart devices market is on an impressive growth trajectory, projected to reach approximately USD 25 billion within the coming years. This expansion is primarily driven by the escalating demand for innovative solutions to manage various structural heart conditions. Understanding Structural Heart Devices...

Continue Reading
MediPharm Labs' Co-Founder Transitions to Board Role

Updated Category News Views 49

Significant Changes at MediPharm Labs MediPharm Labs Corp. (TSX: LABS, OTCQX: MEDIF), a leader in pharmaceutical-quality cannabis extraction and hemp-based products, has announced the departure of its President and Co-Founder, Keith Strachan, from his management role. Effective immediately, Keith will transition to the Board of Directors, where his strategic input will...

Continue Reading
Interactive Brokers Delivers Strong Performance in Q3 2024

Updated Category News Views 280

Interactive Brokers Group Reports Strong Financial Growth Interactive Brokers Group (NASDAQ: IBKR) has announced impressive financial results for the third quarter of 2024, capitalizing on a beneficent market following a U.S. interest rate cut. The company experienced significant year-over-year growth across key metrics such as client accounts, equity, and revenue....

Continue Reading
Publicis Groupe's Share Trading Update and Future Prospects

Updated Category News Views 198

Overview of Recent Share Trading Activities Publicis Groupe has recently engaged in trading its own shares as part of a program approved during its Shareholders’ Meetings. This initiative underscores the company's commitment to managing its share capital effectively, reflecting its ongoing strategy to enhance shareholder value. Transaction Details During the designated...

Continue Reading